Benzinga - by Avi Kapoor, Benzinga Staff Writer.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a “terrific spec” and he recommended buying the same.
On May 9, Recursion Pharmaceuticals reported better-than-expected first-quarter financial results.
Corning Incorporated (NYSE:GLW) has “not been able to generate the kind of return that I've wanted,” Cramer said. “I would not be a buyer all the way up here.”
On May 7, Mizuho analyst John Roberts initiated coverage on Corning with a Neutral rating and announced a price target of $36.
When asked about Intuitive Machines, Inc. (NASDAQ:LUNR), Cramer said, “I'm not there on that.”
On May 14, Intuitive Machines reported a first-quarter GAAP loss of $2.70 per share.
The “Mad Money” host said he would hold off Axon Enterprise, Inc. (NASDAQ:AXON) right now.
On May 6, Axon Enterprise posted better-than-expected results for its first quarter, reporting adjusted earnings of $1.15 per share beating market estimates of 94 cents per share.
“I like defense contractors,” Cramer said when asked about Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS). “I think you stay on it, maybe even buy more.”
On May 7, Kratos Defense & Security posted stronger-than-expected results for its first quarter.
Merit Medical Systems, Inc. (NASDAQ:MMSI) is “good,” Cramer said.
On April 30, Merit Medical Systems posted upbeat results for the first quarter.
Price Action:
- Corning shares gained 0.3% to settle at $36.58 on Wednesday.
- Axon shares fell 1.1% to close at $284.87 on Wednesday.
- Recursion Pharmaceuticals shares slipped 1.6% to settle at $9.36.
- Intuitive Machines shares fell 1.2% to settle at $5.06 on Wednesday.
- Kratos Defense shares fell 1.3% to settle at $21.41.
- Merit Medical shares fell 0.2% to close at $82.14 on Wednesday.
Image: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.